Purchase Order 75N95021P00544

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $99,000 firm fixed price purchase order to Targetmol Chemicals Inc. to synthesize analogs of repsox and intermediates from two ongoing medicinal chemistry projects. Over a six-month period after receipt of order, Targetmol will synthesize the requested compounds and deliver milligram to gram quantities to NCATS along with electronic progress reports, analytical data including LCMS and 1H NMR, and...

The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $2.1 million firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, for the acquisition of two kilograms of cGMP-grade GS-441524 drug substance with an option for two additional kilograms. The drug substance will support preclinical and Phase I clinical studies by the NIH to evaluate GS-441524's potential as a COVID-19 treatment through assessing its safety,...

This is a $90,075 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to American Biochemicals Inc. The contract is for the synthesis of approximately 50 analogs of the small molecule compound metarrestin, which is being developed as an anti-metastasis agent for pancreatic cancer. The goal is to reduce the brain exposure of the compounds while maintaining their...

This federal contract award is for the CRUDE PEPTIDE SYNTHESIS, with a potential value of $22,593.00. The contract was awarded to A & A Labs LLC, doing business as Synthetic Biomolecules, a minority-owned, self-certified small disadvantaged business, and limited liability company. The contract is a purchase order with a firm fixed price, awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. The place of...

The Defense Logistics Agency Troop Support Medical awarded a $1,975.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561854162 ! ADENOSINE 12 MG/4 ML SYRINGE 4ML. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order is for the purchase of adenosine injection syringes and has a period of performance from August 18-21, 2023. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill...

The Defense Logistics Agency Troop Support Medical (DLA) awarded a $349.04 delivery order to DMS Pharmaceutical Group Inc. to supply 4561691468 ! ADENOSINE 6 MG/2 ML SYRINGE 2ML. The firm fixed price order is for a single day of performance from July 17-18, 2023 to be fulfilled at the contractor's facility in Park Ridge, Illinois. DLA manages the Department of Defense's worldwide logistics needs, procuring medical supplies and equipment to support military treatment facilities and readiness...

The federal contract award is for peptide synthesis services in support of the National Institutes of Health (NIH). New England Peptide LLC was awarded an indefinite delivery/indefinite quantity (IDIQ) blanket purchase agreement (BPA) call against the NIH BPA for Peptide Synthesis and Related Services. The prime contractor will provide peptide synthesis and related services to NIH on an as-needed basis from its place of performance in Bethesda, Maryland. The contract start date was February 2,...

A&G Pharmaceutical, Inc. (doing business as Precision Antibody) was awarded a $12,126.75 firm fixed-price purchase order by a civilian federal agency with operations in the Pacific West Area for peptide synthesis services supporting antibody development. The contract, awarded on September 24, 2019, with an ultimate completion date of December 24, 2019, covers the synthesis of two peptide sequences on a per-amino-acid basis. The work will be performed in Parlier, California. No set-aside...

The Defense Logistics Agency awarded a $694.57 delivery order to Amerisourcebergen Drug Corporation for 4561704319 - Adenosine 6 mg/2 ml syringes in quantities of 2 ml each. The firm fixed price order is being fulfilled from the contractor's facility located in Conshohocken, Pennsylvania, with performance spanning August 4 through 7, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite...